GlassScriptPhysician profile
Paige E Bundrick
NPI 1881911683
$1,538.25
in general payments reported to CMS, 2019-2025
14 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.12 · 2020: $114 · 2021: $255 · 2022: $387 · 2023: $201 · 2024: $338 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $551.93 | 2019-2024 | Trumatch, Matrixmidface |
| Abbvie INC. | $227.78 | 2023-2025 | |
| Allergan, INC. | $189.42 | 2022 | |
| Medtronic, INC. | $129.83 | 2024 | Pteye Parathyroid Detection System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.78 | 2020 | |
| Intersect Ent, INC. | $82.54 | 2021 | |
| Olympus America INC. | $64.64 | 2019-2021 | |
| Tempus Ai, INC | $64.03 | 2024-2025 | Xt Cdx |
| Axogen | $28.56 | 2023 | Avance Nerve Graft |
| Smith+Nephew, INC. | $20.28 | 2022 | |
| Amag Pharmaceuticals, INC. | $18.86 | 2019 | |
| Midsouth Orthopedics INC. | $16.04 | 2024 | |
| Galderma Laboratories, L.P. | $15.50 | 2024 | Dysport |
| Sanara Medtech INC. | $15.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Bundrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.